Disclosed herein are cannabinoid receptor ligands of formula (I)
wherein A
1
, A
5
, R
x
, X
4
, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
Disclosed herein are cannabinoid receptor ligands of formula (I)
wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
此处公开的是式 (I) 的大麻素受体配体
其中 A1、A5、Rx、X4 和 z 如说明书中所定义。还公开了包含此类化合物的组合物,以及使用此类化合物和组合物治疗疾病的方法。
SUBSTITUTED BENZAMIDES AS CANNABINOID RECEPTOR LIGANDS
申请人:Abbott Laboratories
公开号:EP2334646A2
公开(公告)日:2011-06-22
US8188135B2
申请人:——
公开号:US8188135B2
公开(公告)日:2012-05-29
[EN] NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS<br/>[FR] COMPOSÉS INÉDITS UTILISABLES EN TANT QUE LIGANDS DES RÉCEPTEURS CANNABINOÏDES
申请人:ABBOTT LAB
公开号:WO2010033543A2
公开(公告)日:2010-03-25
Disclosed herein are cannabinoid receptor ligands of formula (I), wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.